Neil Littman is Business Development Officer at CIRM
CIRM recently released a white paper entitled “Key Tools and Technology Hurdles in Advancing Stem-Cell Therapies” based on a Roundtable held on June 25th in San Francisco (you can download the PDF from our website). The Roundtable was the result of a collaborative effort between CIRM and several industry sponsors, including Roche Diagnostics, Life Technologies, GE Life Sciences, Lonza and Tap Biosystems who each helped sponsor the Roundtable and make the day a success. The Roundtable aimed to bring CIRM-funded academic researchers together with companies interested in developing tools and technologies to help address key research and translational bottlenecks in the field.
In addition to the company sponsors of the roundtable, CIRM collaborated with the Alliance for Regenerative Medicine and the Cell Therapy Catapult (based in the UK), each of whom co-sponsored and co-authored the resulting white paper.
The roundtable is a prime example of bringing together representatives across a broad array of the regenerative medicine community (for-profits, academics and government agencies) for the common goal of advancing the field of stem cell therapy and regenerative medicine. This collaboration among various stakeholders formed the basis for the white paper and will lay the groundwork for subsequent discussions.
CIRM and ARM have already planned a follow-up roundtable meeting to discuss implementing two of the components identified at the roundtable and discussed in the white paper – The Tool Box and the use of suspension culture as a way to address scale-up challenges.
In addition to providing funding, CIRM strategizes the development of specialized tools and technologies to help advance the field. We have also been working to help foster the development of a regulatory pathway for cell therapy. As the saying goes, a rising tide lifts all boats. At the same time, we are working to attract co-funding and follow-on financing for CIRM projects.
If you are interested in learning more about the roundtable, white paper and being a part of future discussions, please let us know.
Below is the full list of entities that participated the June 25th Roundtable:
Beckman Research Institute of City of Hope, BioCardia, Capricor, CCRM, CellSight, Celsense, Cerus, City of Hope, EMD Millipore, Fluidigm, Gamma Medica, GE Life Sciences, Invetech, Life Technologies, Lonza, NanoString, NIH, Nikon Instruments, Progenitor Cell Therapy, Roche Diagnostics, Roche Diagnostics / Genentech, RPT, Stanford, TAP BioSysytems, UC Davis, University of California, Berkeley, ViaCyte
Neil Littman, Business Development Officer at email@example.com